To assess a potential role of Memo1 in kidney disease‐driven Fgf23 expression, we therefore challenged mice of both genotypes with AKI induced by intraperitoneal injection of 240 mg/kg of body weight folic acid. The gene discussed is FGF23; the disease is kidney disorder.